Browse the evidence

Metabolic adaptation (suppressed resting metabolic rate beyond what is predicted by body composition changes) persists for at least 6 years after massive weight loss, acting as a persistent biological barrier to weight maintenance.

If you have lost a significant amount of weight, your body will likely fight to regain it by lowering your metabolic rate, even years later. This is not a failure of willpower but a biological response. To maintain your weight, you must accept that your energy requirements are now lower than they were before you were heavier, and you may need to be more vigilant about energy balance than someone who has never been obese.

When total energy deficit is strictly matched, adding structured aerobic exercise to caloric restriction provides no additional benefit for fat mass loss or abdominal fat distribution compared to caloric restriction alone.

If your goal is purely fat loss and you are willing to restrict calories, adding exercise will not make you lose more fat than dieting alone, provided the total calorie deficit is the same. However, exercise is still valuable for improving cardiovascular health and aerobic fitness, which are independent benefits of weight loss. Do not feel guilty if you skip the gym; your fat loss progress depends on your net energy balance, not the source of the deficit.

Postoperative exercise training does not significantly affect lean body mass in adults undergoing bariatric surgery.

While exercise training may not significantly increase lean body mass after bariatric surgery, it can still improve muscle strength and function. Focus on building strength and endurance rather than just muscle mass.

Both bariatric surgery (RYGB/SG) and structured medical treatment (VLED) result in similar safety profiles regarding hospitalization, need for further surgery, and mortality at 2-year follow-up, despite differences in weight loss magnitude.

Safety outcomes, including hospitalization and mortality, are comparable between bariatric surgery and structured medical treatment at 2 years. This suggests that for many patients, the higher efficacy of surgery does not come with a proportionally higher immediate safety risk compared to medical management.

Unchecked obesity trends in the US population are projected to cause a decline or leveling off of life expectancy in the first half of the 21st century, reversing historical gains.

The steady rise in life expectancy is ending due to obesity. To maintain or extend your lifespan, you must address obesity now, as medical treatments for resulting diseases like diabetes and heart disease are insufficient to counteract the mortality risk. Focus on preventing obesity, especially in children, as the primary lever for longevity.

Quitting smoking is associated with significant weight gain (5.17 lb over 4 years), while continued smoking is associated with less weight gain (-0.70 lb).

If you quit smoking, expect some weight gain (average 5.17 lb over 4 years). This is a common side effect of cessation. Focus on healthy dietary changes and increased physical activity to manage this. The health benefits of quitting smoking far outweigh the risks of weight gain.

Among women, higher consumption of vitamin E from supplements and food sources is not associated with a reduced risk of coronary heart disease.

If you are a woman concerned about heart disease, taking Vitamin E supplements (up to 800 IU/day) or eating Vitamin E-rich foods does not appear to lower your risk of coronary heart disease based on this study. Focus on proven strategies like not smoking, managing blood pressure, and maintaining a healthy weight instead of relying on Vitamin E for heart protection.

Postmenopausal women using combined estrogen and progestin therapy experience a marked decrease in the risk of major coronary heart disease compared to non-users, with the addition of progestin not attenuating the cardioprotective effects of estrogen.

For postmenopausal women considering hormone therapy, current use of combined estrogen and progestin is associated with a significantly lower risk of major coronary heart disease compared to not using hormones. The addition of progestin does not appear to cancel out the heart-protective benefits of estrogen.

Unprocessed red meat consumption is not significantly associated with the incidence of coronary heart disease or type 2 diabetes mellitus.

You do not need to eliminate unprocessed red meat (beef, lamb, pork) from your diet to avoid heart disease or diabetes, based on this analysis. The significant risks are specifically linked to processed meats.

Current postmenopausal hormone therapy is associated with a significantly lower risk of all-cause mortality compared to never use, primarily driven by reduced coronary heart disease mortality.

For postmenopausal women currently using hormone therapy, there is a significant association with reduced all-cause mortality, largely due to lower heart disease death rates. This benefit is most pronounced in women with existing cardiovascular risk factors. However, the benefit diminishes with long-term use (10+ years) due to increased breast cancer mortality. Decisions should be individualized based on risk factors.

The mortality benefit of postmenopausal hormone therapy is attenuated with long-term use (10+ years) due to an increased risk of breast cancer mortality.

If you have been using hormone therapy for 10 or more years, the overall mortality benefit may be reduced due to an increased risk of breast cancer. This does not mean the therapy is harmful, but the net benefit is smaller than for short-term users. Discuss the balance of cardiovascular and breast cancer risks with your doctor.

Postmenopausal hormone therapy provides the greatest mortality benefit for women with existing cardiovascular risk factors.

If you are postmenopausal and have cardiovascular risk factors (such as high blood pressure, high cholesterol, smoking, or diabetes), hormone therapy may offer a significant reduction in your risk of death, primarily by reducing heart disease mortality. This benefit is much larger than for women with low cardiovascular risk.

Obstructive sleep apnea (OSA) is highly prevalent and largely unrecognized in patients with drug-resistant hypertension, with a prevalence of 83% in a specific cohort, significantly higher than in the general population.

If your blood pressure remains high despite taking three or more medications, ask your doctor about screening for sleep apnea. It is a very common, often silent cause of resistant hypertension, and treating it can significantly improve your blood pressure control.

Omega-3 polyunsaturated fatty acid (EPA+DHA) supplementation does not reduce the risk of cardiovascular events or mortality in patients with diabetes mellitus or prediabetes.

If you have diabetes or prediabetes, taking fish oil supplements will not protect your heart or prevent heart attacks. Do not take them for this purpose. Focus on proven diabetes management strategies instead.

Serum leptin levels correlate with subcutaneous (sc) adipose tissue volume, not visceral adipose tissue volume, in Asian Indian men.

Leptin levels reflect subcutaneous fat stores, not the dangerous visceral fat that drives insulin resistance. Do not use leptin as a proxy for visceral adiposity or metabolic risk in Asian Indian men. Focus on visceral fat reduction strategies instead.

Higher intake of total and saturated fat is associated with an increased risk of type 2 diabetes, but this association is not independent of Body Mass Index (BMI) and disappears after adjusting for BMI.

While high fat intake is linked to higher diabetes risk in unadjusted analyses, this link disappears when you account for body weight. This suggests that managing your weight (BMI) is the key factor, not necessarily cutting out all dietary fat. Focus on maintaining a healthy weight rather than fearing fat itself.

Obese women exhibit significantly higher total free-living energy expenditure than lean women, contradicting the hypothesis that obesity is caused by reduced energy expenditure.

If you are obese, your body likely burns more calories than a lean person of similar height due to the energy cost of moving and maintaining larger mass (both fat and fat-free mass). The idea that you have a 'slow metabolism' causing obesity is scientifically unsupported by this study. The issue is likely that you are consuming more energy than you realize, not that you are burning less.

When adjusted for fat-free mass, basal metabolic rate and energy expenditure on thermogenesis plus activity are identical in lean and obese women.

Your basal metabolic rate is determined by your fat-free mass (muscle, organs, bone), not by your fat mass. Obese individuals have higher total BMR simply because they have more fat-free mass to support, not because their metabolism is inherently 'fast' or 'slow' per unit of tissue.

For a given waist circumference or BMI, white adults have higher levels of visceral adipose tissue (VAT) than African-American adults, particularly at higher levels of adiposity.

If you are African-American, your waist circumference might underestimate your visceral fat risk compared to a white person with the same waist size. White adults tend to store more visceral fat at the same waist measurement. This means standard waist cut-offs might need to be lower for white adults to accurately flag visceral fat risk, or higher for African-American adults, though specific thresholds require further research.

Women have higher levels of subcutaneous adipose tissue (SAT) and fat mass (FM) than men for any given waist circumference or BMI.

If you are a woman, your BMI or waist circumference likely underestimates your total body fat and subcutaneous fat compared to a man with the same measurements. Women store more fat in the subcutaneous layer. This means standard 'healthy' ranges for BMI/WC might not reflect the same level of total adiposity for women as they do for men.

High intake of trans-fatty acids is positively associated with an increased risk of coronary death in middle-aged male smokers, independent of saturated fat and cholesterol intake.

For middle-aged male smokers, avoiding trans-fatty acids is critical for reducing coronary death risk. This study suggests that trans-fat intake is a more significant predictor of heart disease mortality than saturated fat or cholesterol intake. Prioritize eliminating trans fats (often found in partially hydrogenated oils) from the diet, as high intake (median 6.2 g/day in the top quintile) was linked to a 39% higher risk of coronary death compared to low intake.

Increasing dietary intake of marine n-3 fatty acids or fish consumption from low levels (1 serving/month) to high levels (6+ servings/week) does not substantially reduce the risk of coronary heart disease in men without preexisting cardiovascular disease.

If you are a healthy man, eating more fish (up to 6 servings a week) or increasing your marine n-3 fatty acid intake is unlikely to significantly lower your risk of coronary heart disease. While fish is part of a healthy diet, this study suggests that dietary amounts are insufficient to provide the protective cardiovascular effects often attributed to fish oil supplements, which require much higher doses.

Socioeconomic status (SES) is positively associated with dietary quality, and the gap in dietary quality between high-SES and low-SES groups widened significantly between 1999 and 2010.

If you have low income or limited education, you may find it harder to improve your diet quality because healthy food is often more expensive and less accessible. This is a structural issue, not a personal failure. Look for community resources, SNAP benefits, or policy initiatives that aim to lower the cost of healthy foods, as individual effort alone may not overcome these barriers.

Despite overall improvements, the absolute dietary quality of the US population remains poor, with many components (vegetables, whole grains, nuts) scoring below 4.0/10.

Even though dietary quality has improved, most Americans still consume far less than the recommended amounts of vegetables, whole grains, and nuts. Focus on incrementally increasing these specific food groups, as they remain the weakest links in the current US diet.